Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Dry Powder Inhaler Market, by Region, 2020-2028 (USD Billion)
1.2.2. Dry Powder Inhaler Market, by Product, 2020-2028 (USD Billion)
1.2.3. Dry Powder Inhaler Market, by Indication, 2020-2028 (USD Billion)
1.2.4. Dry Powder Inhaler Market, by Function, 2020-2028 (USD Billion)
1.2.5. Dry Powder Inhaler Market, by End Use Industries, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Dry Powder Inhaler Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Dry Powder Inhaler Market Dynamics
3.1. Dry Powder Inhaler Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of respiratory disorders.
3.1.1.2. Rising R&D activities and new product launches.
3.1.2. Market Challenges
3.1.2.1. higher cost of devices.
3.1.2.2. Availability of other alternatives.
3.1.3. Market Opportunities
3.1.3.1. Rising healthcare infrastructure in emerging economies.
3.1.3.2. increasing air pollution levels.
Chapter 4. Global Dry Powder Inhaler Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Dry Powder Inhaler Market, by Product
6.1. Market Snapshot
6.2. Global Dry Powder Inhaler Market by Product, Performance - Potential Analysis
6.3. Global Dry Powder Inhaler Market Estimates & Forecasts by Product 2019-2028 (USD Billion)
6.4. Dry Powder Inhaler Market, Sub Segment Analysis
6.4.1. Single Dose Dry Powder Inhalers
6.4.2. Multi Dose Dry Powder Inhalers
Chapter 7. Global Dry Powder Inhaler Market, by Indication
7.1. Market Snapshot
7.2. Global Dry Powder Inhaler Market by Indication, Performance - Potential Analysis
7.3. Global Dry Powder Inhaler Market Estimates & Forecasts by Indication 2019-2028 (USD Billion)
7.4. Dry Powder Inhaler Market, Sub Segment Analysis
7.4.1. Asthma
7.4.2. Chronic Obstructive Pulmonary Disease (COPD)
7.4.3. Pulmonary Arterial Hypertension
7.4.4. Diabetes
7.4.5. Cystic Fibrosis
Chapter 8. Global Dry Powder Inhaler Market, by Function
8.1. Market Snapshot
8.2. Global Dry Powder Inhaler Market by Function, Performance - Potential Analysis
8.3. Global Dry Powder Inhaler Market Estimates & Forecasts by Function 2019-2028 (USD Billion)
8.4. Dry Powder Inhaler Market, Sub Segment Analysis
8.4.1. Manually Operated Inhaler Devices
8.4.2. Digitally Operated Inhaler Devices
Chapter 9. Global Dry Powder Inhaler Market, by End Use Industries
9.1. Market Snapshot
9.2. Global Dry Powder Inhaler Market by End Use Industries, Performance - Potential Analysis
9.3. Global Dry Powder Inhaler Market Estimates & Forecasts by End Use Industries 2019-2028 (USD Billion)
9.4. Dry Powder Inhaler Market, Sub Segment Analysis
9.4.1. Institutional Sales
9.4.2. Retail Sales
9.4.3. Mail Order Pharmacies
Chapter 10. Global Dry Powder Inhaler Market, Regional Analysis
10.1. Dry Powder Inhaler Market, Regional Market Snapshot
10.2. North America Dry Powder Inhaler Market
10.2.1. U.S. Dry Powder Inhaler Market
10.2.1.1. Product breakdown estimates & forecasts, 2019-2028
10.2.1.2. Indication breakdown estimates & forecasts, 2019-2028
10.2.1.3. Function breakdown estimates & forecasts, 2019-2028
10.2.1.4. End Use Industries breakdown estimates & forecasts, 2019-2028
10.2.2. Canada Dry Powder Inhaler Market
10.3. Europe Dry Powder Inhaler Market Snapshot
10.3.1. U.K. Dry Powder Inhaler Market
10.3.2. Germany Dry Powder Inhaler Market
10.3.3. France Dry Powder Inhaler Market
10.3.4. Spain Dry Powder Inhaler Market
10.3.5. Italy Dry Powder Inhaler Market
10.3.6. Rest of Europe Dry Powder Inhaler Market
10.4. Asia-Pacific Dry Powder Inhaler Market Snapshot
10.4.1. China Dry Powder Inhaler Market
10.4.2. India Dry Powder Inhaler Market
10.4.3. Japan Dry Powder Inhaler Market
10.4.4. Australia Dry Powder Inhaler Market
10.4.5. South Korea Dry Powder Inhaler Market
10.4.6. Rest of Asia Pacific Dry Powder Inhaler Market
10.5. Latin America Dry Powder Inhaler Market Snapshot
10.5.1. Brazil Dry Powder Inhaler Market
10.5.2. Mexico Dry Powder Inhaler Market
10.6. Rest of The World Dry Powder Inhaler Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. GlaxoSmithKline Plc
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. AstraZeneca Plc
11.2.3. Novartis AG
11.2.4. Teva Pharmaceutical Industries Limited
11.2.5. Boehringer Ingelheim GmbH
11.2.6. Cipla Limited
11.2.7. Chiesi Farmaceutici S.p.A.
11.2.8. ELPEN Pharmaceutical Co. Inc.
11.2.9. Vectura Group Plc
11.2.10. Beximco Pharmaceuticals Ltd.
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption